CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the anti-inflammatory properties of extracellular vesicles derived from human mesenchymal stem cells for stroke treatment. It aims to enhance the therapeutic potential of these vesicles through specific microRNA enrichment, contributing to regenerative medicine.
Stroke is leading cause of long-term disability in Europe and worldwide with no effective treatment so far.
Inflammation plays a vital role in brain’s response to ischemic stroke with deleterious consequences during early acute phase.
Strong immunomodulatory effect of human mesenchymal stem cell (MSCs) demonstrated in many preclinical stroke models, however, has failed in clinical experiments.
Recent preclinical data indicate that MSCs exert their anti-inflammatory effects via secreted extracell…
EXO BIOLOGICS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Belgium, NIEL
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
